Granahan Investment Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-279,218
| Closed | -$1.83M | – | 195 |
|
|
2020
Q4 | $1.83M | Sell |
279,218
-50,338
| -15% | -$330K | 0.04% | 177 |
|
|
2020
Q3 | $2.19M | Sell |
329,556
-28,566
| -8% | -$190K | 0.07% | 147 |
|
|
2020
Q2 | $2.98M | Buy |
358,122
+92,449
| +35% | +$770K | 0.11% | 131 |
|
|
2020
Q1 | $2.04M | Buy |
265,673
+111,855
| +73% | +$858K | 0.11% | 130 |
|
|
2019
Q4 | $1.28M | Buy |
153,818
+421
| +0.3% | +$3.5K | 0.06% | 152 |
|
|
2019
Q3 | $1.13M | Buy |
153,397
+6,174
| +4% | +$45.6K | 0.06% | 154 |
|
|
2019
Q2 | $1.65M | Sell |
147,223
-9,168
| -6% | -$103K | 0.08% | 152 |
|
|
2019
Q1 | $1.68M | Sell |
156,391
-7,156
| -4% | -$76.9K | 0.09% | 157 |
|
|
2018
Q4 | $2.47M | Sell |
163,547
-3,541
| -2% | -$53.5K | 0.17% | 119 |
|
|
2018
Q3 | $3.09M | Buy |
167,088
+4,584
| +3% | +$84.8K | 0.17% | 125 |
|
|
2018
Q2 | $3.72M | Sell |
162,504
-88
| -0.1% | -$2.01K | 0.22% | 117 |
|
|
2018
Q1 | $4.63M | Buy |
162,592
+71,448
| +78% | +$2.03M | 0.33% | 97 |
|
|
2017
Q4 | $1.92M | Buy |
+91,144
| New | +$1.92M | 0.15% | 146 |
|